Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
Breast cancer affects approximately 12% women worldwide and results in 14% of all cancer-
related fatalities. Breast cancer is commonly categorized into one of four main subtypes …
related fatalities. Breast cancer is commonly categorized into one of four main subtypes …
Wnt signaling in triple-negative breast cancer
Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation,
proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many …
proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many …
MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review
SR Volovat, C Volovat, I Hordila, DA Hordila… - Frontiers in …, 2020 - frontiersin.org
Noncoding RNAs (ncRNAs) include a diverse range of RNA species, including microRNAs
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …
MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer
L Ding, H Gu, X Xiong, H Ao, J Cao, W Lin, M Yu, J Lin… - Cells, 2019 - mdpi.com
Triple-negative breast cancer (TNBC) is the most aggressive, prevalent, and distinct subtype
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …
The emerging role of miRNA clusters in breast cancer progression
Micro RNAs (miRNAs) are small non-coding RNAs that are essential for regulation of gene
expression of the target genes. Large number of miRNAs are organized into defined units …
expression of the target genes. Large number of miRNAs are organized into defined units …
Identification of modulated MicroRNAs associated with breast cancer, diet, and physical activity
L Falzone, M Grimaldi, E Celentano, LSA Augustin… - Cancers, 2020 - mdpi.com
Simple Summary Healthy diet and physical activity are able to induce beneficial molecular
modifications that have been associated with a lower risk of breast cancer (BC) incidence …
modifications that have been associated with a lower risk of breast cancer (BC) incidence …
Cell‐free microRNAs in blood and other body fluids, as cancer biomarkers
B Ortiz‐Quintero - Cell proliferation, 2016 - Wiley Online Library
The discovery of cell‐free micro RNA s (mi RNA s) in serum, plasma and other body fluids
has yielded an invaluable potential source of non‐invasive biomarkers for cancer and other …
has yielded an invaluable potential source of non‐invasive biomarkers for cancer and other …
Evaluation of exosomal miR‐9 and miR‐155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells
Breast cancer is one of the most prevalent cancers in women. Triple‐negative breast cancer
consists 15% to 20% of breast cancer cases and has a poor prognosis. Cancerous …
consists 15% to 20% of breast cancer cases and has a poor prognosis. Cancerous …
miRNAs and other epigenetic changes as biomarkers in triple negative breast cancer
A Mathe, RJ Scott, KA Avery-Kiejda - International journal of molecular …, 2015 - mdpi.com
Triple negative breast cancer (TNBC) is characterised by the lack of receptors for estrogen
(ER), progesterone (PR), and human epidermal growth factor 2 (HER2). Since it cannot be …
(ER), progesterone (PR), and human epidermal growth factor 2 (HER2). Since it cannot be …
Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) …
L Moi, T Braaten, K Al-Shibli, E Lund… - Journal of translational …, 2019 - Springer
Background MicroRNAs (miRNAs) are promising biomarkers due to their structural stability
and distinct expression profile in various cancers. We wanted to explore the miRNA …
and distinct expression profile in various cancers. We wanted to explore the miRNA …